September 18, 2025
September 10, 2025
July 3, 2025
January 10, 2025
Corona Remedies Limited IPO | Important Dates, Price, and More
Author
Shoonya Team
Corona Remedies Limited is launching its ₹655.37 crore IPO, opening for subscription on December 8, 2025. The issue will close on December 10, 2025. The equity shares will be listed on the BSE and NSE, with a tentative listing date of December 15, 2025.
The price band is set at ₹1008 – ₹1062 per share, and the minimum lot size is 14 shares. For retail investors, the minimum investment is ₹14,868 at the upper price band. In comparison, sNII investors must apply for at least 196 shares (₹2,08,152), while bNII investors must bid for at least 952 shares (₹10,11,024).
The IPO is entirely an Offer for Sale, comprising 61.71 lakh shares worth ₹655.37 crore.
JM Financial Ltd. is the book-running lead manager, and Bigshare Services Pvt. Ltd. is the registrar of the issue.
Here are the quick steps to apply for the Corona Remedies IPO!
Corona Remedies Limited | IPO Details
| Detail | Information |
| IPO Opening Date | December 8, 2025 |
| IPO Closing Date | December 10, 2025 |
| Tentative IPO Listing Date | December 15, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹1008 – ₹1062 per share |
| Lot Size | 14 shares |
| Offer for Sale | 61,71,101 shares (₹655.37 Cr) |
| Total Issue Size | 61,71,101 shares (₹655.37 Cr) |
| Employee Discount | ₹54 per share |
| IPO Segment | Main Board – Book Building |
| Listing At | BSE, NSE |
| Registrar | Bigshare Services Pvt. Ltd. |
| Shareholding Pre-Issue | 6,11,60,088 shares |
| Shareholding Post-Issue | 6,11,60,088 shares |
Corona Remedies Limited | Company Overview
Corona Remedies Limited was incorporated in 2004. It is an Indian pharmaceutical company focused on developing and marketing a wide range of branded formulations across therapeutic categories such as gastroenterology, cardiology, dermatology, diabetology, pain management, paediatrics, and respiratory care.
The company has built a strong product portfolio, supported by manufacturing facilities that adhere to stringent quality standards. Corona Remedies follows an extensive domestic distribution network driven by medical representatives and partnerships with healthcare professionals.
With a track record of consistent revenue growth and an expanding product pipeline, the company continues to strengthen its presence in India’s competitive formulation market.
Don’t miss the chance to invest in the Corona Remedies Limited IPO. Open a free Demat account today!
Corona Remedies Limited IPO | Key Details
- IPO Opening Date: December 8, 2025
- IPO Closing Date: December 10, 2025
- Allotment Date: December 11, 2025
- Price Band: ₹1008 – ₹1062 per share
- IPO Size: ₹655.37 Crores (Offer for Sale)
- Refunds Initiated: December 12, 2025
- Shares Credited to Demat: December 12, 2025
- Listing Date: December 15, 2025
- Cut-off Time for UPI Mandate Confirmation: 5 PM on December 10, 2025
Corona Remedies Limited IPO | Financial Overview
Corona Remedies Ltd. delivered a strong performance, with revenue increasing 18% and PAT rising 65% between FY24 and FY25.
Here’s a snapshot of its year-on-year financial performance:
Amounts are in ₹ Crore
| Detail | 31-Mar-25 | 31-Mar-24 | Change | Change % |
| Assets | 929.86 | 830.58 | +99.28 | +11.95% |
| Total Income | 1,202.35 | 1,020.93 | +181.42 | +17.77% |
| Profit After Tax | 149.43 | 90.50 | +58.93 | +65.14% |
| EBITDA | 245.91 | 161.19 | +84.72 | +52.54% |
| Net Worth | 606.34 | 480.41 | +125.93 | +26.21% |
| Reserves & Surplus | 545.18 | 419.25 | +125.93 | +30.04% |
| Total Borrowing | 62.70 | 134.14 | -71.44 | -53.25% |
Corona Remedies Limited IPO | FAQs
The Corona Remedies IPO opens on December 8, 2025, and closes on December 10, 2025.
The Corona Remedies IPO price band is ₹1008 – ₹1062, and the minimum lot size is 14 shares. Retail investors can invest with ₹14,868 at the upper band.
You can check the Corona Remedies IPO allotment status on the registrar’s website, Bigshare Services Pvt. Ltd., using PAN, DP ID, or application number.
The registrar for the Corona Remedies IPO is Bigshare Services Pvt. Ltd., handling application processing, allotment, refunds, and share credit to Demat.
Refunds of the Corona Remedies IPO will be processed on December 12, 2025, and shares will be credited to Demat accounts on the same day.
The face value of shares under the Corona Remedies IPO is ₹10 per share.
The Corona Remedies IPO consists of 61.71 lakh shares, entirely an Offer for Sale.
Source: https://www.nseindia.com/
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.
Explore Our Offerings
Stocks
Trade equities across NSE and BSE with zero delivery charges. Invest, hold or sell with a seamless experience.
Future & Options
Execute complex strategies with simple tools and real-time data.
IPOs
Apply to the latest IPOs in just a few taps. Stay updated and capture opportunities as they open.